A comparison of risk factors for relapse in opiate-related and stimulant-related substance use disorders: A cross-sectional multicenter study.
inventory of drug-taking situations (IDTS)
opiates
recurrence
stimulants
substance use disorders
Journal
Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing
ISSN: 1547-5069
Titre abrégé: J Nurs Scholarsh
Pays: United States
ID NLM: 100911591
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
13
12
2022
received:
21
06
2022
accepted:
21
12
2022
medline:
4
5
2023
pubmed:
4
1
2023
entrez:
3
1
2023
Statut:
ppublish
Résumé
Recognizing the specific factors in relapse disorders related to each substance can help improve treatment methods and adopt more effective preventive strategies. This study aimed to compare the situational factors associated with relapse in opiate-related disorders with stimulant-related disorders (SRDs) of those referred to substance misuse treatment centers. This study was a cross-section type. The study participants were 150 clients with SRDs and 150 with opiate-related disorders. Samples were selected using two stages random sampling method. Data were collected through a demographic questionnaire and the Inventory of Drug-Taking Situations (IDTS). The mean score of IDTS in the two groups was significantly different (X̄ This study reveals that despite some similarities, relapse-related situational factors in opiates and stimulants differ. Some situational factors, such as social pressure and coping with unpleasant emotions, play a more critical role in relapse to both stimulant and opiate groups.
Substances chimiques
Opiate Alkaloids
0
Types de publication
Multicenter Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
566-576Informations de copyright
© 2023 Sigma Theta Tau International.
Références
AbdelWahab, M. A., Abou el Magd, S. F., Grella, C. E., Enaba, D. A., & Abdel Maqsoud, R. (2019). An examination of motives for tramadol and heroin use in an Egyptian sample. Journal of Addictive Diseases, 37(3-4), 123-134. https://doi.org/10.1080/10550887.2019.1623650
Alcohol and Drug Foundation. (2022). Stimulants. https://adf.org.au/drug-facts/stimulants/
Amin-Esmaeili, M., Rahimi-Movaghar, A., Sharifi, V., Hajebi, A., Radgoodarzi, R., Mojtabai, R., Hefazi, M., & Motevalian, A. (2016). Epidemiology of illicit drug use disorders in Iran: Prevalence, correlates, comorbidity and service utilization results from the Iranian mental health survey. Addiction, 111(10), 1836-1847. https://doi.org/10.1111/add.13453
Amirabadizadeh, A., Nakhaee, S., Ghasemi, S., Benito, M., Bazzazadeh Torbati, V., & Mehrpour, O. (2020). Evaluating drug use relapse event rate and its associated factors using Poisson model. Journal of Substance Use, 26(1), 60-66. https://doi.org/10.1080/14659891.2020.1779359
Amirabadizadeh, A., Nezami, H., Vaughn, M. G., Nakhaee, S., & Mehrpour, O. (2018). Identifying risk factors for drug use in an Iranian treatment sample: A prediction approach using decision trees. Substance Use & Misuse, 53(6), 1030-1040. https://doi.org/10.1080/10826084.2017.1392981
Andersson, H. W., Wenaas, M., & Nordfjaern, T. (2019). Relapse after inpatient substance use treatment: A prospective cohort study among users of illicit substances. Addictive Behaviors, 90, 222-228. doi:10.1016/j.addbeh.2018.11.008
Atadokht, A., Hajloo, N., Karimi, M., & Narimani, M. (2015). The role of family expressed emotion and perceived social support in predicting addiction relapse. International Journal of High Risk Behaviors & Addiction, 4(1), e21250. https://doi.org/10.5812/ijhrba.21250
Badiani, A., Belin, D., Epstein, D., Calu, D., & Shaham, Y. (2011). Opiate versus psychostimulant addiction: The differences do matter. Nature Reviews Neuroscience, 12(11), 685-700. https://doi.org/10.1038/nrn3104
Brecht, M.-L., & Herbeck, D. (2014). Time to relapse following treatment for methamphetamine use: A long-term perspective on patterns and predictors. Drug and Alcohol Dependence, 139, 18-25. https://doi.org/10.1016/j.drugalcdep.2014.02.702
Dafny, N., & Rosenfeld, G. C. (2017). Chapter 33 - neurobiology of drugs of abuse. In P. M. Conn (Ed.), Conn's translational neuroscience (pp. 715-722). Academic Press. doi:10.1016/B978-0-12-802381-5.00052-X
Ekhtiari, H., Noroozi, A., Farhoudian, A., Radfar, S. R., Hajebi, A., Sefatian, S., Zare-Bidoky, M., Razaghi, E. M., Mokri, A., Rahimi-Movaghar, A., & Rawson, R. (2020). The evolution of addiction treatment and harm reduction programs in Iran: A chaotic response or a synergistic diversity? Addiction, 115(7), 1395-1403. https://doi.org/10.1111/add.14905
Epstein, D. H., & Preston, K. L. (2010). Daily life hour by hour, with and without cocaine: An ecological momentary assessment study. Psychopharmacology, 211(2), 223-232. https://doi.org/10.1007/s00213-010-1884-x
Faraone, S. V. (2018). The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neuroscience & Biobehavioral Reviews, 87, 255-270. https://doi.org/10.1016/j.neubiorev.2018.02.001
Farrell, M., Martin, N. K., Stockings, E., Bórquez, A., Cepeda, J. A., Degenhardt, L., Ali, R., Tran, L. T., Rehm, J., Torrens, M., Shoptaw, S., & McKetin, R. (2019). Responding to global stimulant use: Challenges and opportunities. Lancet, 394(10209), 1652-1667. https://doi.org/10.1016/S0140-6736(19)32230-5
Fitzgerald, L. C. (2018). The effect of stress and locus of control on continued substance use during opioid substitution treatment for opioid dependency. https://core.ac.uk/download/pdf/226397381.pdf
Goldman-Hasbun, J., Nosova, E., Kerr, T., Wood, E., & DeBeck, K. (2019). Homelessness and incarceration associated with relapse into stimulant and opioid use among youth who are street-involved in Vancouver, Canada. Drug and Alcohol Review, 38(4), 428-434. https://doi.org/10.1111/dar.12921
Gowin, J. L., Ball, T. M., Wittmann, M., Tapert, S. F., & Paulus, M. P. (2015). Individualized relapse prediction: Personality measures and striatal and insular activity during reward-processing robustly predict relapse. Drug and Alcohol Dependence, 152, 93-101. https://doi.org/10.1016/j.drugalcdep.2015.04.018
Hartwell, K. J., Back, S. E., McRae-Clark, A. L., Shaftman, S. R., & Brady, K. T. (2012). Motives for using: A comparison of prescription opioid, marijuana and cocaine dependent individuals. Addictive Behaviors, 37(4), 373-378. https://doi.org/10.1016/j.addbeh.2011.11.014
Kadam, M., Sinha, A., Nimkar, S., Matcheswalla, Y., & De Sousa, A. (2017). A comparative study of factors associated with relapse in alcohol dependence and opioid dependence. Indian Journal of Psychological Medicine, 39(5), 627-633. https://doi.org/10.4103/IJPSYM.IJPSYM_356_17
Kassani, A., Niazi, M., Hassanzadeh, J., & Menati, R. (2015). Survival analysis of drug abuse relapse in addiction treatment centers. International Journal of High Risk Behaviors & Addiction, 4(3), e23402. https://doi.org/10.5812/ijhrba.23402
Khan, T. A., Dutta, A., & Subedi, S. (2018). Factors associated with relapse in men with alcohol dependence versus opioid dependence: A comparative study from Western Nepal. Journal of Nepalgunj Medical College, 16(2), 69-73. https://doi.org/10.3126/jngmc.v16i2.24888
Klein, M. (2020). Relapse into opiate and crack cocaine misuse: A scoping review. Addiction Research & Theory, 29(2), 129-147. https://doi.org/10.1080/16066359.2020.1724972
Lu, C. Y. (2009). Observational studies: A review of study designs, challenges and strategies to reduce confounding. International Journal of Clinical Practice, 63(5), 691-697. https://doi.org/10.1111/j.1742-1241.2009.02056.x
McCabe, S. E., West, B. T., Strobbe, S., & Boyd, C. J. (2018). Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates. Journal of Substance Abuse Treatment, 93, 38-48. https://doi.org/10.1016/j.jsat.2018.07.012
Marel, C., Sunderland, M., Mills, K. L., Slade, T., Teesson, M., & Chapman, C. (2019). Conditional probabilities of substance use disorders and associated risk factors: Progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids. Drug and Alcohol Dependence, 194, 136-142. https://doi.org/10.1016/j.drugalcdep.2018.10.010
Mattoo, S., Chakrabarti, S., & Anjaiah, M. (2009). Psychosocial factors associated with relapse in men with alcohol or opioid dependence. Indian Journal of Medical Research, 130(6), 702-708.
McCabe, C., & Dixon, S. (2000). Testing the Validity of Cost-Effectiveness Models. Pharmaco Economics, 17(5), 501-513. https://doi.org/10.2165/00019053-200017050-00007
Montanari, C., Stendardo, E., De Luca, M. T., Meringolo, M., Contu, L., & Badiani, A. (2015). Differential vulnerability to relapse into heroin versus cocaine-seeking as a function of setting. Psychopharmacology, 232(13), 2415-2424. https://doi.org/10.1007/s00213-015-3877-2
Moradinazar, M., Farnia, V., Alikhani, M., Karyani, A. K., Rezaei, S., Rezaeian, S., … Najafi, F. (2020). Factors related to relapse in patients with substance-related disorders under methadone maintenance therapy: Decision tree analysis. OMJ, 35(1), e89. https://doi.org/10.5001/omj.2020.07
Murphy, D. A., Hser, Y. I., Huang, D., Brecht, M. L., & Herbeck, D. M. (2010). Self-report of longitudinal substance use: A comparison of the UCLA Natural History Interview and the Addiction Severity Index. Journal of Drug Issues, 40(2), 495-515. https://doi.org/10.1177/002204261004000210
Noorbala, A. A., Saljoughian, A., Bagheri Yazdi, S. A., Faghihzadeh, E., Farahzadi, M. H., Kamali, K., Faghihzadeh, S., Hajebi, A., Akhondzadeh, S., & Mousavi, M. T. (2020). Evaluation of drug and alcohol abuse in people aged 15 years and older in Iran. Iranian Journal of Public Health, 49(10), 1940-1946. https://doi.org/10.18502/ijph.v49i10.4697
Noroozi, A., Malekinejad, M., & Rahimi-Movaghar, A. (2018). Factors influencing transition to Shisheh (Methamphetamine) among young people who use drugs in Tehran: A qualitative study. Journal of Psychoactive Drugs, 50(3), 214-223. https://doi.org/10.1080/02791072.2018.1425808
Ortiz-Aguayo, D., Cetó, X., De Wael, K., & del Valle, M. (2022). Resolution of opiate illicit drugs signals in the presence of some cutting agents with use of a voltammetric sensor array and machine learning strategies. Sensors and Actuators B: Chemical, 357, 131345. https://doi.org/10.1016/j.snb.2021.131345
Pashaei, T., Razaghi, O. M., Foroushani, A. R., Tabatabaei, M. G., Moeeni, M., Turner, N. E., … Shojaeizadeh, D. (2013). Assessing the validity and reliability of the Farsi version of inventory drug-taking situations. Iranian Journal of Psychiatry, 8(2), 80-85.
Rhodes, L., Nash, C., Moisan, A., Scott, D. C., Barkoh, K., Warner W. C., Sawyer, J. R., … Kelly, D. M. (2015). Does preoperative orientation and education alleviate anxiety in posterior spinal fusion patients? A prospective, randomized study. Journal of Pediatric Orthopedics Part B, 35(3), 276-279. https://doi.org/10.1097/bpo.0000000000000260
Romano, I., Costello, M. J., Ropp, C., Li, Y., Sousa, S., Bruce, D., Roth, D., MacKillop, J., & Rush, B. (2019). Evaluating the short-term impact of a tobacco-free policy in an inpatient addiction treatment setting. Journal of Substance Abuse Treatment, 107, 50-59. https://doi.org/10.1016/j.jsat.2019.09.007
Rosenberg, H., Grant, J., & Davis, A. (2020). Acceptance of non-abstinence as an outcome goal for individuals diagnosed with substance use disorders: A narrative review of published research. Journal of Studies on Alcohol and Drugs, 81(4), 405-415.
Salem, B., Gonzales-Castaneda, R., Ang, A., Rawson, R. A., Dickerson, D., Chudzynski, J., Penate, J., Dolezal, B., Cooper, C. B., & Mooney, L. J. (2022). Craving among individuals with stimulant use disorder in residential social model-based treatment - Can exercise help? Drug and Alcohol Dependence, 231, e109247. https://doi.org/10.1016/j.drugalcdep.2021.109247
Shafiei, E., Hoseini, A. F., Bibak, A., & Azmal, M. (2014). High risk situations predicting relapse in self-referred addicts to Bushehr Province substance abuse treatment centers. International Journal of High Risk Behaviors & Addiction, 3(2), e16381. https://doi.org/10.5812/ijhrba.16381
Shahraki, G., Sedaghat, Z., & Fararouei, M. (2019). Family and social predictors of substance use disorder in Iran: A case-control study. Substance Abuse Treatment, Prevention, and Policy, 14, e17. https://doi.org/10.1186/s13011-019-0201-x
Sliedrecht, W., de Waart, R., Witkiewitz, K., & Roozen, H. G. (2019). Alcohol use disorder relapse factors: A systematic review. Psychiatry Research, 278, 97-115. https://doi.org/10.1016/j.psychres.2019.05.038
United Nations Office on Drugs and Crime (UNODC). (2019). World drug report 2018. https://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_1_EXSUM.pdf
Steinbuchel, P., & Greenhill, L. (2020). Stimulants: Definition, pharmacology, indications, side effects, and treatment strategies. In: P. Riederer, G. Laux, T. Nagatsu, W. Le, & C. Riederer (Eds.), Neuro Psychopharmacotherapy (pp 1-29). Springer, Cham. https://doi.org/10.1007/978-3-319-56015-1_324-1
Zarghami, M. (2015). Iranian common attitude toward opium consumption. The Iranian Journal of Psychiatry and Behavioral Sciences, 9(2), e2074. https://doi.org/10.17795/ijpbs2074